ifa systems Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 10/21/2023)
| Balance Sheet | Total Assets | 10,900,000.00 | ROE | – |
| Balance Sheet | Total Equity | 6,500,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -1.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 1.00 | – | – |
| Cashflow | Operating Cash Flow | 2.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 0.37 | Div. Yield | – |
| Income | Net Income | 448,000.00 | P/E | – |
| Income | Shares Outstanding | 2,750,000.00 | P/B | – |
| Income | Total Revenue | 8,293,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Ifa Systems AG (Ifa) is a Germany-based company that provides information technology (IT) solutions for eye care specialists. It develops and distributes software, medicine information systems for clinics and medical practitioners, particularly for ophthalmic surgeons, ophthalmologists, technicians, nurses, as well as eye care managers and administrators. The Company focuses on picture archiving and communication systems (PACS) and electronic medical record solutions (EMR), and provides clinical information systems (CIS), interface application connectivity (IAC) solutions, telemedicine services (TMS), and disease registries/clinical research (DR/CR). It also provides consulting and system integration services, as well as training. It operates through ifa systems informationssysteme fuer augenaerzte GmbH, ifa united-i-tech Inc, integration.AG, Inoveon Corp and MedKaizen AG.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.ifasystems.de
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more